Peloton Wealth Strategists »

Neurocrine Biosciences shares owned by Peloton Wealth Strategists

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Peloton Wealth Strategists from 13F filings

Historical chart of Peloton Wealth Strategists investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Peloton Wealth Strategists consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Peloton Wealth Strategists

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 14k 140.41
2025-06-30 $1.9M 15k 125.69
2025-03-31 $1.7M 15k 110.61
2024-12-31 $1.9M 14k 136.52
2024-09-30 $405k 3.5k 115.22

More positions owned by Peloton Wealth Strategists

Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Ibonds Dec 2028 Term Corporate Etf Etf (IBDT)
Amazon Stock (AMZN)
Mastercard Incorporated Cl A Stock (MA)
Microsoft Corp Stock (MSFT)
Ishares Ibonds Dec 2027 Term Corporate Etf Etf (IBDS)
Ishares Ibonds Dec 2029 Term Corporate Etf Etf (IBDU)
Jpmorgan Chase & Co Stock (JPM)
Ishares Ibonds Dec 2026 Term Corporate Etf Etf (IBDR)
Ishares Ibonds Dec 2025 Term Corporate Etf Etf (IBDQ)
Ishares Ibonds Dec 2030 Term Corporate Etf Etf (IBDV)
Rtx Corporation Stock (RTX)
Thermo Fisher Scientific Stock (TMO)
Salesforce Stock (CRM)
Goldman Sachs Group Stock (GS)

View all positions for Peloton Wealth Strategists

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management

View all funds holding Neurocrine Biosciences